All In Biotech

Drug Trial Radar · NCT01451541

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).

A 12-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis

Last checked: Nov 19, 2026Latest source record: May 6, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 848 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

848

Actual

Start

Oct 2011

Primary completion

Dec 2012

Study completion Dec 2012

Sponsor

Lead sponsor
Sumitomo Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Oct 13, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 6 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study of ciclesonide nasal aerosol administered once daily to male and premenarchal female subjects 6 to 11 years of age with a diagnosis of PAR.

Conditions

  • Perennial Allergic Rhinitis
  • PAR

Interventions

  • Ciclesonide nasal aerosol 37 mcgDrug

    ciclesonide nasal aerosol 37mcg - the dose is administered as 1 actuation per nostril to give a total dose of 37

  • ciclesonide nasal aerosol 74 mcgDrug

    ciclesonide nasal aerosol 74 mcg - the dose is administered as 1 actuation per nostril to give a total dose of 74 mcg

  • PlaceboDrug

    Placebo - one dose per nostril

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Change From Baseline in Average Daily Subject-reported AM and PM Reflective Total Nasal Symptom Scores (rTNSS) Averaged Weekly Over the First 6 Weeks of the Double-blind Treatment.Time frame: Weeks 0-6

Locations

60 sites in 1 country. Site status is shown where the registry gives one.

  • Burke Pharmaceutical Research

    Hot Springs, Arkansas

  • Arkansas Pediatric Clinic

    Little Rock, Arkansas

  • West Coast Clinical Trials, LLC

    Costa Mesa, California

  • Premier Health Research Center

    Downey, California

  • Allergy and Asthma Specialists Medical Group

    Huntington Beach, California

  • Pediatric Care Medical Group

    Huntington Beach, California

  • Allergy and Asthma Assoc of Southern CA

    Mission Veijo, California

  • Center for Clinical Trials, LLC

    Paramount, California

  • Allergy Associates Medical Group

    San Diego, California

  • Allergy and Asthma Medical Group & Research Center

    San Diego, California

  • Sansum Clinic

    Santa Barbara, California

  • Colorado Allergy and Asthma Centers, PC

    Centennial, Colorado

  • IMMUNOe International Research Centers

    Centennial, Colorado

  • Storms Clinical Research Institute

    Colorado Springs, Colorado

  • Ashtma and Allergy Associates

    Pueblo, Colorado

  • DataQuest Medical Research, LLC

    Lawerenceville, Georgia

  • Aeroallergy Research Labs of Savannah

    Savannah, Georgia

  • Atlanta Allergy and Asthma Clinic

    Stockbridge, Georgia

  • Clinical Research Atlanta

    Stockton, Georgia

  • Sneeze, Wheeze, & Itch Associates, LLC

    Normal, Illinois

  • College Park Family Care Center

    Lenexa, Kansas

  • Family Allergy and Asthma Research Institute

    Louisville, Kentucky

  • Gordon Raphael, MD

    Bethesda, Maryland

  • Northeast Medical Research Associates Inc

    North Dartmouth, Massachusetts

  • Respiratory Medicine Research Institute of Michigan, PLC

    Ypsilanti, Michigan

  • Clinical Research Institute Inc

    Plymouth, Minnesota

  • Clinical Research of the Ozarks

    Warrensburg, Missouri

  • Clinical Research Group of Montana

    Bozeman, Montana

  • The Asthma and Allergy Center, PC

    Bellevue, Nebraska

  • Boys Town National Research Hospital

    Boys Town, Nebraska

  • Atlantic Research Center LLC

    Ocean City, New Jersey

  • Island Medical Research P.C.

    Rockville Centre, New York

  • Allergy and Asthma Center of NC, PA

    High Point, North Carolina

  • Catalyst Medical Center

    Fargo, North Dakota

  • Sterling Research Group Ltd

    Cincinnati, Ohio

  • Toledo Center for Clinical Research

    Sylvania, Ohio

  • Allergy, Asthma & Clinical Research Center

    Oklahoma City, Oklahoma

  • Amy Darter, MD

    Oklahoma City, Oklahoma

  • Cyn3rgy Research

    Gresham, Oregon

  • Baker Allergy Asthma and Dermatolgy Research Center, LLC

    Lake Oswego, Oregon

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.